Comparison of Intrathecal Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine on Post-operative Urinary Retention in Knee Joint Arthroscopic Surgeries

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

May 25, 2022

Study Completion Date

July 15, 2022

Conditions
Post-Op Complication
Interventions
DRUG

hyperbaric bupivacaine and dexmedetomidine

In a 3 ml syringe, 5 µg dexmedetomidine was added to the 2 ml of 10 mg hyperbaric bupivacaine, to have a total volume of 2.5 ml for intrathecal spinal injection over 3 minute without barbotage

DRUG

Bupivacaine-Fentanyl group

In a 3 ml syringe, 25 μg fentanyl was added to the 2 ml of 10 mg hyperbaric bupivacaine, to have a total volume of 2.5 ml for intrathecal spinal injection over 3 minute without barbotage

Trial Locations (1)

Unknown

Faculty of Medicine, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05596552 - Comparison of Intrathecal Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine on Post-operative Urinary Retention in Knee Joint Arthroscopic Surgeries | Biotech Hunter | Biotech Hunter